For comments, suggestions
Created with Raphaël 2.1.0 12.12.2017 Filing date 16.02.2018 Validation fee payment 31.10.2018 (A1) Patent application published 18.07.2019 AGEPI application filing date 31.10.2019 (T2) Translation of the validated European patent 12.12.2022 Valid until 31.08.2023 (MM4E) Forfeiture of rights 31.07.2024 (MM4E) Forfeiture of rights

Patent lapsed


(210)Number of the EPO application17818220
(220)Filing date of the EPO application2017.12.12
(80)EPO patent specification publication (B)EPB nr. 24/2019, 2019.06.12
(110)EPO patent number3359172
(11)Number of the documentMD 3359172 T2
(21)Number of the applicatione 2018 0808
(71)Name(s) of applicant(s), code of the country4D PHARMA PLC, GB;
(72)Name(s) of inventor(s), code of the countryJEFFERY Ian, IE;
SHANAHAN Fergus, IE;
O'TOOLE Paul, IE;
STEVENSON Alex, GB;
MULDER Imke, GB;
SAVIGNAC Helene, GB;
(73)Name(s) of owner(s), code of the country4D PHARMA PLC, GB;
(54)Title of the inventionCompositions comprising bacterial strains
(13)Kind-of-document code T2
(51)International Patent Classification A61K 35/74 (2015.01.01); A61P 1/14 (2006.01.01); A61P 29/00 (2006.01.01)
(19)CountryGB
(41)Date of publication of the application2018.10.31
(49)Date of publication of the translation of the validated European patent specification2019.10.31
(30)Priority201621123, 2016.12.12, GB
(74)Patent attorney(Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova
(86)International applicationPCT/GB2017/053722, 2017.12.12
(87)International publicationWO 2018/109461, 2018.06.21
Up
/Inventions/details/3359172